Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 628

1.

Investigation of hormone receptor expression and its prognostic value in endometrial stromal sarcoma.

Park JY, Baek MH, Park Y, Kim YT, Nam JH.

Virchows Arch. 2018 Jul;473(1):61-69. doi: 10.1007/s00428-018-2358-5. Epub 2018 Jun 4.

PMID:
29869299
2.

Molecular biomarkers for uterine leiomyosarcoma and endometrial stromal sarcoma.

Tsuyoshi H, Yoshida Y.

Cancer Sci. 2018 Jun;109(6):1743-1752. doi: 10.1111/cas.13613. Epub 2018 May 23. Review.

3.

Gene expression profiling of low-grade endometrial stromal sarcoma indicates fusion protein-mediated activation of the Wnt signaling pathway.

Przybyl J, Kidzinski L, Hastie T, Debiec-Rychter M, Nusse R, van de Rijn M.

Gynecol Oncol. 2018 May;149(2):388-393. doi: 10.1016/j.ygyno.2018.03.007. Epub 2018 Mar 12.

PMID:
29544705
4.

Impact of oophorectomy and hormone suppression in low grade endometrial stromal sarcoma: A multicenter review.

Stewart LE, Beck TL, Giannakopoulos NV, Rendi MH, Isacson C, Goff BA.

Gynecol Oncol. 2018 May;149(2):297-300. doi: 10.1016/j.ygyno.2018.03.008. Epub 2018 Mar 11.

PMID:
29534832
5.

Systemic treatment in adult uterine sarcomas.

Desar IME, Ottevanger PB, Benson C, van der Graaf WTA.

Crit Rev Oncol Hematol. 2018 Feb;122:10-20. doi: 10.1016/j.critrevonc.2017.12.009. Epub 2017 Dec 14. Review.

6.

A remarkable response to pazopanib, despite recurrent liver toxicity, in a patient with a high grade endometrial stromal sarcoma, a case report.

Verschoor AJ, Warmerdam FARM, Bosse T, Bovée JVMG, Gelderblom H.

BMC Cancer. 2018 Jan 22;18(1):92. doi: 10.1186/s12885-018-3999-0.

7.

Endometrial stromal sarcomas and related neoplasms: new developments and diagnostic considerations.

Hoang L, Chiang S, Lee CH.

Pathology. 2018 Feb;50(2):162-177. doi: 10.1016/j.pathol.2017.11.086. Epub 2017 Dec 22. Review.

PMID:
29275929
8.

Endometrial stromal sarcoma in combination with mixed type endometrial carcinomas: A case report and literature review.

Xiu XX, Wang HL, Yun-Yi L, Fan-Dou K, Jin-Ping H.

Medicine (Baltimore). 2017 Dec;96(49):e8928. doi: 10.1097/MD.0000000000008928. Review.

9.

[Values of JAZF1 gene rearrangement detected by fluorescence in-situ hybridization in diagnosis of endometrial stromal tumours].

Bai QM, Chang B, Tu XY, Bi R, Cheng YF, Huang D, Zhu XL, Wu LJ, Zhang X, Zhou XY, Yang WT.

Zhonghua Bing Li Xue Za Zhi. 2017 Nov 8;46(11):769-774. doi: 10.3760/cma.j.issn.0529-5807.2017.11.007. Chinese.

PMID:
29136690
10.

Oncogenic HrasG12V expression plus knockdown of Cdkn2a using ecotropic lentiviral vectors induces high-grade endometrial stromal sarcoma.

Brandt LP, Albers J, Hejhal T, Catalano A, Wild PJ, Frew IJ.

PLoS One. 2017 Oct 5;12(10):e0186102. doi: 10.1371/journal.pone.0186102. eCollection 2017.

11.

Cardiac metastatic endometrial stromal sarcoma 17 years after hysterectomy.

Manuel V, Dinato FJ, Gutierrez PS, Siqueira SAC, Gaiotto FA, Jatene FB.

J Card Surg. 2017 Oct;32(10):636-638. doi: 10.1111/jocs.13221. Epub 2017 Oct 1.

PMID:
28967156
12.

Endometrial Stromal Sarcoma of the Uterus: Magnetic Resonance Imaging Findings Including Apparent Diffusion Coefficient Value and Its Correlation With Ki-67 Expression.

Li HM, Liu J, Qiang JW, Gu WY, Zhang GF, Ma FH.

Int J Gynecol Cancer. 2017 Nov;27(9):1877-1887. doi: 10.1097/IGC.0000000000001114.

PMID:
28906310
13.

[Pneumothorax Caused by Multiple Pulmonary Metastases of a Uterine Endometrial Stromal Sarcoma;Report of a Case].

Shomura S, Suzuki H, Yada M, Kondo C.

Kyobu Geka. 2017 Sep;70(10):871-873. Japanese.

PMID:
28894063
14.

Myxoid Mesenchymal Tumors of the Uterus: An Update on Classification, Definitions, and Differential Diagnosis.

Busca A, Parra-Herran C.

Adv Anat Pathol. 2017 Nov;24(6):354-361. doi: 10.1097/PAP.0000000000000164. Review.

PMID:
28787279
15.

Fusion of the genes BRD8 and PHF1 in endometrial stromal sarcoma.

Micci F, Brunetti M, Dal Cin P, Nucci MR, Gorunova L, Heim S, Panagopoulos I.

Genes Chromosomes Cancer. 2017 Dec;56(12):841-845. doi: 10.1002/gcc.22485. Epub 2017 Sep 6.

16.

Endometrial stromal sarcoma-A retropsective analysis of factors affecting recurrence.

Agarwal R, Rajanbabu A, Nair IR, Satish C, Jose G, Unikrishnan UG.

Eur J Obstet Gynecol Reprod Biol. 2017 Sep;216:92-97. doi: 10.1016/j.ejogrb.2017.07.011. Epub 2017 Jul 14.

PMID:
28738297
17.

Neuron navigator-2 and cyclin D2 are new candidate prognostic markers in uterine sarcoma.

Davidson B, Hellesylt E, Holth A, Danielsen HE, Skeie-Jensen T, Katz B.

Virchows Arch. 2017 Sep;471(3):355-362. doi: 10.1007/s00428-017-2172-5. Epub 2017 Jun 22.

PMID:
28643014
18.

Validation of a Mitotic Index Cutoff as a Prognostic Marker in Undifferentiated Uterine Sarcomas.

Hardell E, Josefson S, Ghaderi M, Skeie-Jensen T, Westbom-Fremer S, Cheek EH, Bell D, Selling J, Schoolmeester JK, Måsbäck A, Davidson B, Carlson JW.

Am J Surg Pathol. 2017 Sep;41(9):1231-1237. doi: 10.1097/PAS.0000000000000894.

PMID:
28622181
19.

BCOR is a robust diagnostic immunohistochemical marker of genetically diverse high-grade endometrial stromal sarcoma, including tumors exhibiting variant morphology.

Chiang S, Lee CH, Stewart CJR, Oliva E, Hoang LN, Ali RH, Hensley ML, Arias-Stella JA 3rd, Frosina D, Jungbluth AA, Benayed R, Ladanyi M, Hameed M, Wang L, Kao YC, Antonescu CR, Soslow RA.

Mod Pathol. 2017 Sep;30(9):1251-1261. doi: 10.1038/modpathol.2017.42. Epub 2017 Jun 16.

20.

Low-grade and high-grade endometrial stromal sarcoma: A National Cancer Database study.

Seagle BL, Shilpi A, Buchanan S, Goodman C, Shahabi S.

Gynecol Oncol. 2017 Aug;146(2):254-262. doi: 10.1016/j.ygyno.2017.05.036. Epub 2017 Jun 7.

PMID:
28596015

Supplemental Content

Loading ...
Support Center